Procurement Resource Thumbnail Book Image

Global Acute Kidney Injury Treatment Industry Report: Regional Analysis; Key Segmentation and Scope; Industry Opportunities and Challenges; Market Analysis; Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis, Key Indicators for Demand, Key Indicators for Price; Value Chain Analysis; Industry Events and Developments; Competitive Landscape, 2022-2027

Acute Kidney Injury Treatment Industry Report by Regional Category Spend, Price Analysis, Key Demand, and Price Indicators, and Best Buying Practices


The global Acute Kidney Injury Treatment market reached a value of about USD 39.26 billion in 2021. The industry is projected to grow at a CAGR of around 6.1% in the forecast period of 2022-2027 to reach a value of about USD 56.00 billion by 2027.

The global Acute Kidney Injury Treatment industry report gives a comprehensive analysis of the industry, including key segments, trends, drivers, restraints, the competitive landscape, and other essential market aspects. The rising acute kidney injury condition cases are driving the demand for the treatment market. North America is the highest category spender by region, driving the need for the Acute Kidney Injury Treatment industry.

Industry Definition and Segmentation

Acute kidney injury (AKI), which includes both injury (structural damage) and impairment, is characterised as a sudden (within hours) decline in kidney function (loss of operation). Rarely does a condition have single, identifiable pathogenesis. The kidneys may abruptly cease functioning if one has acute kidney injury. It might result in a slight decline in kidney function to total renal failure. AKI makes it difficult for your kidneys to maintain the proper fluid balance in the body and ends in a buildup of waste products in the blood. The Acute Kidney Injury Treatment industry report comprises segments by Type (Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury, Postrenal Acute Kidney Injury, Others), Treatment (Dialysis, Supportive Care), End-Use (Hospitals, Ambulatory Surgical Centres, Others) and Region (North America, Europe, Asia Pacific, the Middle East, and Africa, and South America).

North American Region is Driving the Growth of the Industry

North America holds a significant share in the industry due to the growing use of cutting-edge technology in the area. The treatment market in the region is predicted to have considerable growth due to the robust continuing clinical pipeline and the developments in technology, which further enable more efficient products.

The industry is being driven by an ageing population and an increase in acute kidney injury cases. Furthermore, the growing number of dialysis facilities, among other treatment modalities, is further boosting the market demand. In addition, the danger of kidney damage has grown due to the rising elderly population, poor nutrition, and heavy alcohol use. Acetaminophen and other drug overdoses, hepatitis, autoimmune disorders, and metabolic illnesses are other causes contributing to the market's expansion.

Best Procurement Practices

The global Acute Kidney Injury Treatment industry report by Procurement Resource gives an in-depth analysis of the best buying practices followed by major global Acute Kidney Injury Treatment regions across the globe, such as engagement models, contract terms, and buyer and supplier negotiation levers, among others.

Category Management Studies

The treatment depends on the condition of the patient. The doctor can advise intravenous (IV) fluids if a deficiency in fluids in the blood is the root cause of acute renal failure. In some situations, swelling in the arms and legs occurs, and drugs are advised to help the body flush out additional fluids. The doctor may advise calcium, glucose, or sodium polystyrene sulfonate if the kidneys aren't effectively removing potassium from your blood to avoid the buildup of excessive potassium levels in the blood. Also, Temporary hemodialysis, or dialysis, may be performed to assist in eliminating toxins and extra fluids from your body while your kidneys repair if toxins build up in your blood. An artificial kidney removes waste from the blood as it is pumped out of the body.

Improvements in Diagnostic Technologies, Further Driving the Acute Kidney Injury Treatment Market

The improvements are aiding the industry in diagnostic technologies and increasing the number of acute renal injuries. Additionally, it is projected that rising healthcare costs and government measures to improve the healthcare system would boost market revenue. The critical renal injury treatment market in the Asia Pacific is also anticipated to grow due to government research and development activities and programmes.

However, the high cost of dialysis therapy and the low patient compliance to a long-term treatment plan will likely hamper the market growth.

The regional markets for the industry can be divided into North America, South America, Europe, the Middle East and Africa, and the Asia Pacific.

Key Industry Players Mentioned in the Acute Kidney Injury Treatment Industry Report

  • Angion
  • AM-Pharma B.V.
  • Baxter International, Inc.
  • Fresenius Medical Care Holdings, Inc.
  • Asahi Kasei Medical Co., Ltd.

Market Landscape

Major companies are investing in creating innovative therapies, which are anticipated to provide lucrative prospects for market participants to expand. Key players are concentrating on adopting growth tactics, including product launch, regulatory approval, and research and development. Several other firms are developing diagnostic technologies to simplify their product offerings in growing markets with various product portfolios. To provide patients with cutting-edge care, industry leaders are concentrating on creating automated, portable, and technologically sophisticated dialysis equipment. They are also incorporating advanced technology like artificial intelligence and the internet of things (IoT) to diversify their product offering.

Key Initiatives by Companies

  • In April 2021, Vifor Pharma, a large pharmaceutical company, and Angion Biomedica Corp, a late-stage biopharmaceutical company, announced that enrollment for Angion's AKI-002-15 study, a Phase II trial of ANG-3777 in patients at risk of cardiac surgery-related acute kidney injury, had been completed (CSA-AKI).
  • Abionyxx reported in June 2021 that the first patient had been enrolled in its Phase-2a clinical research using CER-001 to treat septic patients with a high risk of acute kidney damage.

1    Preface        
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Acute Kidney Injury Treatment Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Acute Kidney Injury Treatment Historical Market (2017-2021) 
    8.3    Global Acute Kidney Injury Treatment Market Forecast (2022-2027)
    8.4    Global Acute Kidney Injury Treatment Market by Type
        8.4.1    Prerenal Acute Kidney Injury
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
        8.4.2    Intrinsic Renal Acute Kidney Injury
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
        8.4.3    Postrenal Acute Kidney Injury
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2017-2021)
            8.4.3.3    Forecast Trend (2022-2027)
        8.4.4    Others
    8.5    Global Acute Kidney Injury Treatment Market by Treatment
        8.5.1    Dialysis
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    Supportive Care
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
    8.6    Global Acute Kidney Injury Treatment Market by End User
        8.6.1    Hospitals
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2017-2021)
            8.6.1.3    Forecast Trend (2022-2027)
        8.6.2    Ambulatory Surgical Centres
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2017-2021)
            8.6.2.3    Forecast Trend (2022-2027)
        8.6.3    Others
    8.7    Global Acute Kidney Injury Treatment Market by Region
        8.7.1    Market Share
            8.7.1.1    North America
            8.7.1.2    Europe
            8.7.1.3    Asia Pacific
            8.7.1.4    Latin America
            8.7.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    Key Indicators for Demand
    10.4    Key Indicators for Price  
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Angion
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    AM-Pharma B.V.
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Baxter International, Inc. 
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Fresenius Medical Care Holdings, Inc. 
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Asahi Kasei Medical Co., Ltd.
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    B. Braun Melsungen AG  
            12.2.6.1    Company Overview
            12.2.6.2    Product Portfolio
            12.2.6.3    Demographic Reach and Achievements
            12.2.6.4    Certifications
        12.2.7    Others
13    Industry Events and Developments

Request Sample
Key Questions Answered in the Report

The global Acute Kidney Injury Treatment market size was valued at USD 39.26 billion in 2021.

In the forecast period of 2022-2027, the market is projected to grow at a CAGR of 6.1%.

The developments in the treatment are one of the essential drivers of the Acute Kidney Injury Treatment market growth.

Angion, AM-Pharma B.V., Baxter International, Inc., Fresenius Medical Care Holdings, Inc., Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, and Others are some of the major companies in the market.

The North American region of the Acute Kidney Injury Treatment industry holds a significant share in the market.

Analyst Review

The global Acute Kidney Injury Treatment market attained a value of USD 39.26 billion in 2021, driven by an ageing population and an increase in acute kidney injury cases. Aided by the improvements in diagnostic technologies and government research and development activities and programmes, the market is expected to witness further growth in the forecast period of 2022-2027, growing at a CAGR of 6.1%. The market is projected to reach USD 56.00 billion by 2027. Some of the leading players in the industry are Angion, AM-Pharma B.V., Baxter International, Inc., Fresenius Medical Care Holdings, Inc., Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, and Others.

Procurement Resources' detailed research approach explores deep into the industry, encompassing the macro and micro aspects of the industry. Its team of experts uses a combination of cutting-edge analytical tools and their expertise, thus, delivering its customers with market insights that are accurate and actionable and help them remain ahead of their competition.

Compare test & Choose the Right Report Version for You

Why Procurement Resource?

RIGHT PEOPLE

At Procurement Resource our analysts are selected after they are assessed thoroughly on having required qualities so that they can work effectively and productively and are able to execute projects based on the expectations shared by our clients. Our team is hence, technically exceptional, strategic, pragmatic, well experienced and competent.

RIGHT METHODOLOGY

We understand the cruciality of high-quality assessments that are important for our clients to take timely decisions and plan strategically. We have been continuously upgrading our tools and resources over the past years to become useful partners for our clientele. Our research methods are supported by most recent technology, our trusted and verified databases that are modified as per the needs help us serve our clients effectively every time and puts them ahead of their competitors.

RIGHT PRICE

Our team provides a detailed, high quality and deeply researched evaluations in competitive prices, that are unmatchable, and demonstrates our understanding of our client’s resource composition. These reports support our clientele make important procurement and supply chains choices that further helps them to place themselves ahead of their counterparts. We also offer attractive discounts or rebates on our forth coming reports.

RIGHT SUPPORT

Our vision is to enable our clients with superior quality market assessment and actionable evaluations to assist them with taking timely and right decisions. We are always ready to deliver our clients with maximum results by delivering them with customised suggestions to meet their exact needs within the specified timeline and help them understand the market dynamics in a better way.

Similar Reports
Global Nutmeg Industry Report: Size, Trend, Analysis and Forecast 2022-2027

Email Delivery   Price: $ 999.00

The global nutmeg market reached a value of about 130 thousand tonnes in 2021. The industry is further expected to grow at a CAGR of about 6% in the forecast period of 2022-2027 to reach a value of around 180 thousand tonnes by 2027.

Read More
Global HEOR Service Industry Report: Size, Trend, Analysis and Forecast 2022-2027

Email Delivery   Price: $ 999.00

The global HEOR market reached a value of about USD 1364.3 million in 2021. The industry is further expected to grow at a CAGR of about 12.81% in the forecast period of 2022-2027 to reach a value of around USD 2779.2 million by 2027.

Read More
Global Artificial Intelligence Industry Report: Analysis and Forecast 2022-2027

Email Delivery   Price: $ 999.00

The global Artificial Intelligence market reached a value of about USD 192 Billion in 2021. The industry is projected to grow at a CAGR of around 23% in the forecast period of 2022-2027 to reach a value of about USD 664.86 Billion by 2027.

Read More

NEWSLETTER

Get latest News About Procurement Resource
Subscribe for news